Wilson Sonsini Goodrich & Rosati advised Glycomine on the transaction. Glycomine, a biotechnology company focused on developing transformative new therapies for orphan diseases, announced a $115...
Glycomine’s $115 Million Series C Financing Round
ThayerMahan’s $20 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised ThayerMahan, Inc. on the transaction. ThayerMahan, Inc. announced it closed $20 million in follow-on Series C funding led by Hanwha Asset...
PSG’s Growth Investment in 4me
Wilson Sonsini Goodrich & Rosati advised 4me on the transaction. 4me®, a SaaS-based IT Service Management (ITSM) and Enterprise Service Management (ESM) software vendor, has announced...
ThayerMahan’s $30 Million Series C Round
Wilson Sonsini Goodrich & Rosati advised ThayerMahan on the transaction. ThayerMahan, a world leader in autonomous maritime surveillance solutions, announced the closing of a $30 million...




























